User profiles for Thaddeus Wadas
Thad J WadasAssociate Professor of Radiology, University of Iowa Verified email at uiowa.edu Cited by 4067 |
Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease
TJ Wadas, EH Wong, GR Weisman… - Chemical …, 2010 - ACS Publications
Molecular imaging is the visualization, characterization, and measurement of biological
processes at the molecular and cellular levels in humans and other living systems. Molecular …
processes at the molecular and cellular levels in humans and other living systems. Molecular …
Vapochromism and its structural basis in a luminescent Pt (II) terpyridine− nicotinamide complex
A novel Pt(II) terpyridine complex that has a nicotinamide moiety linked to the terpyridyl ligand
has been synthesized in good yield and studied structurally and spectroscopically. The …
has been synthesized in good yield and studied structurally and spectroscopically. The …
Platinum chromophore-based systems for photoinduced charge separation: a molecular design approach for artificial photosynthesis
S Chakraborty, TJ Wadas, H Hester… - Inorganic …, 2005 - ACS Publications
Photoinduced charge separation is a fundamental step in photochemical energy conversion.
In the design of molecularly based systems for light-to-chemical energy conversion, this …
In the design of molecularly based systems for light-to-chemical energy conversion, this …
[HTML][HTML] Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development
We report our initial investigations into the use of tetraazamacrocycles as zirconium-89
chelators. We describe the synthesis and complete characterization of several Zr …
chelators. We describe the synthesis and complete characterization of several Zr …
[HTML][HTML] Recent advances in zirconium-89 chelator development
The interest in zirconium-89 ( 89 Zr) as a positron-emitting radionuclide has grown considerably
over the last decade due to its standardized production, long half-life of 78.2 h, favorable …
over the last decade due to its standardized production, long half-life of 78.2 h, favorable …
[HTML][HTML] Development of targeted alpha particle therapy for solid tumors
Targeted alpha-particle therapy (TAT) aims to selectively deliver radionuclides emitting α-particles
(cytotoxic payload) to tumors by chelation to monoclonal antibodies, peptides or small …
(cytotoxic payload) to tumors by chelation to monoclonal antibodies, peptides or small …
64Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity
OBJECTIVES: The α v β 3 integrin is a cell adhesion molecule known to be involved in stages
of angiogenesis and metastasis. In this study, the chelators CB-TE2A and diamsar were …
of angiogenesis and metastasis. In this study, the chelators CB-TE2A and diamsar were …
[HTML][HTML] Preliminary therapy evaluation of 225Ac-DOTA-c (RGDyK) demonstrates that Cerenkov radiation derived from 225Ac daughter decay can be detected by …
The theranostic potential of 225 Ac-based radiopharmaceuticals continues to increase as
researchers seek innovative ways to harness the nuclear decay of this radioisotope for …
researchers seek innovative ways to harness the nuclear decay of this radioisotope for …
Radiolabeling of TETA-and CB-TE2A-conjugated peptides with copper-64
TJ Wadas, CJ Anderson - Nature protocols, 2006 - nature.com
The number of radiopharmaceuticals containing copper radionuclides for diagnostic
imaging and targeted radiotherapy has grown considerably over the past few decades. This …
imaging and targeted radiotherapy has grown considerably over the past few decades. This …
Molecular targeted α-particle therapy for oncologic applications
OBJECTIVE. A significant challenge facing traditional cancer therapies is their propensity to
significantly harm normal tissue. The recent clinical success of targeting therapies by …
significantly harm normal tissue. The recent clinical success of targeting therapies by …